Living your best life while you're living with MS means learning how to manage and overcome the physical and psychological limitations that MS tries to impose. This week's guest, Dr. Kathleen Zackowski, Senior Director of Patient Management, Care, and Rehabilitation Research for the National MS Society, takes us on a deep dive into MS rehabilitation & symptom management.       We're also talking about the FDA approval of Gilenya for treating Pediatric MS, President Donald Trump's announced "blueprint to lower (prescription) drug prices," and next week's International Progressive MS Alliance Scientific Congress on Rehabilitation & Symptom Management.   And...we're announcing some very special podcast episodes coming your way next week!!   We have a lot to talk about! Are you ready for RealTalk MS? ____________

The RealTalk MS Podcast & Alexa  1:35

FDA Approves Gilenya For Pediatric MS  3:13

President Trump Announces His Prescription Drug Strategy  4:30

MS Rehabilitation & Symptom Management  6:37

International Progressive MS Alliance Scientific Congress  9:35

Special Upcoming Podcast Episodes  10:32

Interview with Dr. Kathleen Zackowski  11:21

___________

LINKSIf your podcast app doesn’t show these links, you’ll find them in the show notes at www.RealTalkMS.com

The RealTalk MS Podcast Alexa Skill

FDA Approves Gilenya for Pediatric MS

The International Progressive MS Alliance

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 32 Guest: Dr. Kathleen Zackowski Hosted By: Jon Strum

Tags: MS, multipleSclerosis, Alexa, Gilenya, MSRehabilitation,  Rehabilitation, AllianceCongress2018, RealTalkMS